CytomX Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
CytomX Therapeutics, Inc. has filed 794 SEC EDGAR filings since 28 Sep 2010

SEC filing history

Showing 351-375 of 794 matching filings.

Per page
25
Current page
15
S-8 File 333-253452

S-8

Filing date
24 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K - YE 2020 EARNINGS

Filing date
24 Feb 2021
Reporting date
24 Feb 2021
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Feb 2021
Reporting date
25 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89140

SC 13G/A

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89140

AMENDMENT NO. 2 TO THE SCHEDULE 13G

Filing date
11 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89140

SCHEDULE 13G/A

Filing date
10 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
04 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89140

SC 13G/A filing

Filing date
02 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89140

SCHEDULE 13G

Filing date
29 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89140

SC 13G/A filing

Filing date
29 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89140

SCHEDULE 13G

Filing date
26 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-228203

424B5

Filing date
21 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-228203

424B5

Filing date
19 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Dec 2020
Reporting date
23 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
28 Dec 2020
Reporting date
18 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Dec 2020
Reporting date
16 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
18 Dec 2020
Reporting date
16 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Dec 2020
Reporting date
30 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Dec 2020
Reporting date
30 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Dec 2020
Reporting date
30 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89140

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Filing date
10 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .